State
72,940 recalls have nationwide distribution and so reach DC. 2,795 additional recalls listed District of Columbia specifically in their distribution scope.
Of the 2,795 recalls naming District of Columbia we have scored against our rubric, 240 (9%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 946 (34%) are Severe.
Which agencies issued them
These figures cover only the 2,795 recalls whose distribution notice names District of Columbia specifically. The 72,940 nationwide recalls listed below reach every state, so counting them here would make every state page show the same numbers.
CorNeat Vision is recalling 630 CorNeat EverPatch units after reviewed complaints identified that conjunctival wound dehiscence may result in early exposure of the surgical patch.
GenoGenix is recalling Bacteriostatic Water for Injection in all strengths and presentations, covering all lots within expiry, for lack of assurance of sterility.
GenoGenix is recalling B6 (Pyridoxine HCl) for Injections in all strengths and presentations, covering all lots within expiry, for lack of assurance of sterility.
GenoGenix is recalling GHK-Cu (Copper Peptide) for Injection in all strengths and presentations, covering all lots within expiry, for lack of assurance of sterility.
CorNeat Vision is recalling 180 EverPatch+ units after reviewed complaints identified that conjunctival wound dehiscence may result in early exposure of the surgical patch.
GenoGenix is recalling Low Solubility Peptide Reconstitution Solution for Injection in all strengths and presentations, covering all lots within expiry, for lack of assurance of sterility.
GenoGenix is recalling Semaglutide for Injection, 20 mg in 10 mL multi-dose vials, from two lots for lack of assurance of sterility.
GenoGenix is recalling Cerebrolysin for Injection in all strengths and presentations, covering all lots within expiry, for lack of assurance of sterility.
GenoGenix is recalling Oxytocin for Injection in all strengths and presentations, covering all lots within expiry, for lack of assurance of sterility.
GenoGenix is recalling L-Arginine HCl for Injection in all strengths and presentations, covering all lots within expiry, for lack of assurance of sterility.
Acuity Specialty Products is recalling AFCO isopropyl alcohol-based hand sanitizer because required receipt testing of incoming alcohol was not performed, so methanol risk could not be excluded.
GenoGenix is recalling Thymosin Beta-4 (TB4) for Injection, 15mg, in all presentations from a single lot for lack of assurance of sterility.
GenoGenix is recalling L-Carnitine for Injection in all strengths and presentations, covering all lots within expiry, for lack of assurance of sterility.
GenoGenix is recalling Sermorelin lyophilized powder for reconstitution, 10mg in a 10 mL multi-dose vial, from a single lot for lack of assurance of sterility.
GenoGenix is recalling NAD+ injection at 50 mg/mL and 100 mg/mL in 10 mL multi-dose vials, covering all lots within expiry, for lack of assurance of sterility.
GenoGenix is recalling Proline for Injection in all strengths and presentations, covering all lots within expiry, for lack of assurance of sterility.
GenoGenix is recalling Lysine for Injection in all strengths and presentations, covering all lots within expiry, for lack of assurance of sterility.
GenoGenix is recalling B12 Hydroxocobalamin for Injection in all strengths and presentations, covering all lots within expiry, for lack of assurance of sterility.
GE is recalling 7,302 AW Server systems after identifying a security vulnerability that, if exploited, could compromise the confidentiality, integrity and availability of patient data.
GenoGenix is recalling Retatrutide for Injection, 60mg/10mL vial, from a single lot for lack of assurance of sterility.
GenoGenix is recalling Pentosan for Injection in all strengths and presentations, covering all lots within expiry, for lack of assurance of sterility.
GenoGenix is recalling CoQ10 for Injection in all strengths and presentations, covering all lots within expiry, for lack of assurance of sterility.
GenoGenix is recalling Calcium Chloride for Injection in all strengths and presentations, covering all lots within expiry, for lack of assurance of sterility.
Major Pharmaceuticals is recalling 866 blister packs of Chlorpromazine Hydrochloride Tablets USP 100 mg because N-Nitroso Desmethyl Chlorpromazine was present above the recommended intake limit.
GenoGenix is recalling Vitamin D3 for Injection in all strengths and presentations, covering all lots within expiry, for lack of assurance of sterility.